Tuesday, February 02, 2016 9:26:50 PM
This drug is a no holds barred blockbuster.
LightLake Therapeutics, (LLTP), holds that FDA approval for Nasal Spray NARCAN and farmed out the production to privately held Adapt Pharma.
Very few investors have ever heard of Nasal Spray NARCAN and even less have heard of LightLake Therapeutics. Almost all of the publicity so far makes note of privately held Adapt Pharma, with no mention of LLTP.
Going back aways some investors here pointed out DGLY, the body cam maker, and how big the stock would be as the body cam for all cops issue gathered steam.
They were months ahead of the issue and right in spades, of course.
Imo, Nasal Spray NARCAN and the micro-float company holding the FDA approval will be bigger. Much bigger.
Watch how this snowballs.
http://www.philly.com/philly/education/20160202_Pa__schools_can_get_heroin-antidote_drug.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM